John V. Cox
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 14
- Cancer Treatment and Pharmacology 8
- Pancreatic and Hepatic Oncology Research 4
-
- Lung Cancer Treatments and Mutations 4
- Surgery top 5%
-
- Economic and Financial Impacts of Cancer 14
- Health Systems, Economic Evaluations, Quality of Life 14
-
- Palliative Care and End-of-Life Issues 6
- Co-authors
- Jean A. MarounGary ElfringLangdon L. MillerLeonard B. SaltzNicoletta PirottaPaula K. LockerMalcolm J. MooreLouis Fehrenbacher
- Journals
- Journal of Oncology Practice (18 papers)Journal of Clinical Oncology (9 papers)JCO Oncology Practice (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
John V. Cox
62 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Hepatology 1.1k
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 1.1k
- Pathology and Forensic Medicine 499
- Surgery 829
Countries citing papers authored by John V. Cox
This map shows the geographic impact of John V. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John V. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John V. Cox more than expected).
Fields of papers citing papers by John V. Cox
This network shows the impact of papers produced by John V. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John V. Cox. The network helps show where John V. Cox may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John V. Cox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 21 | |
| 3 | 2021 | 3 | |
| 4 | 2020 | 25 | |
| 5 | 2019 | 6 | |
| 6 | 2015 | 1 | |
| 7 | 2015 | 1 | |
| 8 | 2008 | 156 | |
| 9 | Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancerbreakdown → | 2000 | 2368 |
| 10 | 2000 | 8 | |
| 11 | 1999 | 162 | |
| 12 | 1998 | 9 | |
| 13 | 1998 | 1 | |
| 14 | 1997 | 25 | |
| 15 | 1993 | 17 | |
| 16 | 1992 | 18 | |
| 17 | 1992 | 19 | |
| 18 | 1991 | 9 | |
| 19 | 1990 | 14 | |
| 20 | China : emerging world power | 1968 | 1 |
About John V. Cox
John V. Cox is a scholar working on Oncology, Economics and Econometrics, Public Health, Environmental and Occupational Health, Geriatrics and Gerontology and Hepatology, having authored 65 papers that have together received 4.3k indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (14 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers), Colorectal Cancer Treatments and Studies (14 papers), Cancer Treatment and Pharmacology (8 papers), Palliative Care and End-of-Life Issues (6 papers), Pancreatic and Hepatic Oncology Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). The work is most often cited by research in Hepatology (1.1k citations), Oncology (3.4k citations), Pulmonary and Respiratory Medicine (1.1k citations), Pathology and Forensic Medicine (499 citations) and Surgery (829 citations). John V. Cox has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jean A. Maroun, Gary Elfring, Langdon L. Miller, Leonard B. Saltz, Nicoletta Pirotta, Paula K. Locker, Malcolm J. Moore, Louis Fehrenbacher, Stephen P. Ackland and Lee S. Rosen. Their work appears in journals such as Journal of Oncology Practice, Journal of Clinical Oncology, JCO Oncology Practice, Cancer and American Society of Clinical Oncology Educational Book.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.